Alnair Therapeutics

About:

Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.

Top Investors: Gaingels, OCA Ventures, Portal Innovations, CJM Ventures, George Shultz Innovation Fund

Description:

Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult-to-treat malignancies. It has created a first-of-its-kind drug delivery technology that uses the unique features of cancer metabolism to improve drug targeting and penetration directly into cancer cells, hence enhancing patient treatment outcomes.